Joint effect of platelet distribution width and stent surface area on major adverse cardiovascular events after percutaneous coronary intervention

被引:2
|
作者
Zhang, Xiaofeng [1 ,2 ]
Ge, Haiyan [3 ]
Gong, Xiaoxuan [1 ]
Wang, Jing [1 ]
Li, Chunjian [1 ]
机构
[1] Nanjing Med Univ, Dept Cardiol, Affiliated Hosp 1, Nanjing, Peoples R China
[2] Nanjing Univ Chinese Med, Hosp Nanjing 2, Nanjing, Peoples R China
[3] Zhongshan Rehabil Hosp Jiangsu Prov, Dept Ultrasound, Nanjing, Peoples R China
关键词
Stent surface area(SSA); platelet distribution width (PDW); percutaneous coronary intervention (PCI); major adverse cardiovascular events (MACEs); DRUG-ELUTING STENTS; BARE METAL STENTS; ARTERY-DISEASE; MARKER; RISK;
D O I
10.21037/apm-21-1088
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: This study was conducted to analyze the influences of stent surface area (SSA), platelet distribution width (PDW), and the joint effect of these 2 risk factors on major adverse cardiovascular events (MACEs) in patients treated with percutaneous coronary intervention (PCI) together with drug-eluting stent (DES) implantation. Methods: Based on a cross-sectional survey conducted between 2011 and 2012, a prospective cohort study was enrolled consiting of 442 patients who had undergone PCI with DES implantation. We categorized the participants into 4 subgroups according to PDW and SSA. Cox proportional hazards models were applied to explore the correlation of PDW and SSA with MACE incidence. Results: During the 12 months of follow-up time, 87 patients experienced MACEs, which included 4 deaths (4.6%), 5 nonfatal myocardial infarctions (MIs) (5.75%), 9 ischemic strokes (10.34%), and 73 clinically relevant bleeding episodes (83.91%). The risks of MACEs were decreased by SSA and increased by PDW. However, the association of PDW or SSA with MACE was not statistically significant. Compared with the patients with PDW >= 13.5% and SSA <358.14 mm(2), the multivariable adjusted hazard ratios [HRs; 95% confience interval (CI)] of the total MACEs for the patients with PDW <13.5% and SSA >= 358.14 mm(2), and with PDW >= 13.5% and SSA >= 358.14 mm(2) were 0.94 (95% CI: 0.55-1.64) and 0.37 (95% CI: 0.18-0.76), respectively. Additionally, the patients in the group of PDW <13.5% and SSA <358.14 mm(2), and PDW >= 13.5% and SSA >= 358.14 mm(2) had respective HRs of 0.47 (95% CI: 0.24-0.91) and 0.28 (95% CI: 0.13-0.63) for 12-month bleeding events when PDW >= 13.5% and SSA <358.14 mm(2)was used as a group reference. Conclusions: Our present results suggest that the joint effect of PDW and SSA was significantly correlated to MACE development in the patients treated with PCI (with DES implantation).
引用
收藏
页码:5633 / 5640
页数:8
相关论文
共 50 条
  • [41] Impact of heart failure severity and major bleeding events after percutaneous coronary intervention on subsequent major adverse cardiac events
    Ikebe, So
    Ishii, Masanobu
    Otsuka, Yasuhiro
    Nakamura, Taishi
    Tsujita, Kenichi
    Matoba, Tetsuya
    Kohro, Takahide
    Oba, Yusuke
    Kabutoya, Tomoyuki
    Imai, Yasushi
    Kario, Kazuomi
    Kiyosue, Arihiro
    Mizuno, Yoshiko
    Nochioka, Kotaro
    Nakayama, Masaharu
    Iwai, Takamasa
    Miyamoto, Yoshihiro
    Sato, Hisahiko
    Akashi, Naoyuki
    Fujita, Hideo
    Nagai, Ryozo
    INTERNATIONAL JOURNAL OF CARDIOLOGY CARDIOVASCULAR RISK AND PREVENTION, 2023, 18
  • [42] Impact of heart failure severity and major bleeding events after percutaneous coronary intervention on subsequent major adverse cardiac events
    Ikebe, S.
    Ishi, M.
    Otsuka, Y.
    Nakamura, T.
    Tsujita, K.
    Matoba, T.
    Kohro, T.
    Oba, Y.
    Kabutoya, T.
    Imai, Y.
    Kario, K.
    Kiyosue, A.
    Mizuno, Y.
    Nochioka, K.
    Nakayama, M.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [43] Elevated Baseline Serum Fibrinogen: Effect on 2-Year Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention
    Ang, Lawrence
    Behnamfar, Omid
    Palakodeti, Samhita
    Lin, Felice
    Pourdjabbar, Ali
    Patel, Mitul P.
    Reeves, Ryan R.
    Mahmud, Ehtisham
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (11):
  • [44] Association of Body Mass Index With Major Cardiovascular Events and With Mortality After Percutaneous Coronary Intervention
    Park, Duk-Woo
    Kim, Young-Hak
    Yun, Sung-Cheol
    Ahn, Jung-Min
    Lee, Jong-Young
    Kim, Won-Jang
    Kang, Soo-Jin
    Lee, Seung-Whan
    Lee, Cheol Whan
    Park, Seong-Wook
    Park, Seung-Jung
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2013, 6 (02) : 146 - 153
  • [45] Effect of cardiac rehabilitation nursing management on quality of life and adverse cardiovascular events in patients after percutaneous coronary intervention
    Cao, Chunhui
    Wang, Rong
    Wang, Xiaofang
    Lu, Honge
    Song, Liting
    Li, Huijuan
    Kang, Nan
    Ma, Le
    MINERVA SURGERY, 2023, 78 (05): : 597 - 599
  • [46] Analysis of Risk Factors for Major Adverse Cardiovascular Events in Patients with Coronary Stent Restenosis after Revascularization
    Yang, Zhuoxuan
    Wang, Tianjie
    Dong, Ying
    Liu, Long
    Xue, Xuan
    Wu, Jine
    Hao, Liuyi
    Yuan, Jiansong
    Cui, Jingang
    Qiao, Shubin
    Yang, Weixian
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2023, 24 (05)
  • [47] Contemporary Predictors of Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention: A Nationally Representative US Sample
    Horne, Benjamin D.
    Atreja, Nipun
    Venditto, John
    Wilson, Thomas
    Muhlestein, Joseph B.
    St. Clair, Joshua R.
    Knowlton, Kirk U.
    Khan, Naeem D.
    Bhalla, Narinder
    Anderson, Jeffrey L.
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (10)
  • [48] The problem with composite end points in cardiovascular studies - The story of major adverse cardiac events and percutaneous coronary intervention
    Kip, Kevin E.
    Hollabaugh, Kim
    Marroquin, Oscar C.
    Williams, David O.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (07) : 701 - 707
  • [49] Using the Super Learner algorithm to predict risk of major adverse cardiovascular events after percutaneous coronary intervention in patients with myocardial infarction
    Xiang Zhu
    Pin Zhang
    Han Jiang
    Jie Kuang
    Lei Wu
    BMC Medical Research Methodology, 24
  • [50] Development and validation of a nomogram for major adverse cardiovascular events after chronic total occlusion percutaneous coronary intervention for ischemic heart failure
    Du, Jiaqi
    Yang, Lulu
    Hao, Zhengyang
    Li, Huan
    Yang, Chunlei
    Wang, Xing
    Zhang, Zhaozhi
    Du, Youyou
    Zhang, Yanzhou
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2024,